
factorize.bio is a Berlin-based biotech startup that leverages ultra-fast AI technology to accelerate drug discovery for any protein, including those with unknown structures. Their proprietary platform screens over 10 billion molecules in less than a day, enabling the identification of novel drug candidates and optimizing hit-to-lead development. By integrating proprietary data and utilizing a vast database of protein-ligand activity points, they provide tailored predictions that enhance the drug development process. Their innovative approach aims to unlock previously undruggable targets, making them a valuable partner for pharma and biotech companies seeking to innovate in drug discovery.

factorize.bio is a Berlin-based biotech startup that leverages ultra-fast AI technology to accelerate drug discovery for any protein, including those with unknown structures. Their proprietary platform screens over 10 billion molecules in less than a day, enabling the identification of novel drug candidates and optimizing hit-to-lead development. By integrating proprietary data and utilizing a vast database of protein-ligand activity points, they provide tailored predictions that enhance the drug development process. Their innovative approach aims to unlock previously undruggable targets, making them a valuable partner for pharma and biotech companies seeking to innovate in drug discovery.